{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:07:38Z","timestamp":1776060458195,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T00:00:00Z","timestamp":1257465600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ANZ Journal of Surgery"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Endoscopic surveillance of individuals with Barrett's oesophagus is undertaken to detect early stage oesophageal malignancy. The impact of a surveillance programme on endoscopy resources and disease detection is uncertain.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> In 2004, we commenced a structured Barrett's oesophagus surveillance programme. The surveillance protocol specifies surveillance interval and number of oesophageal biopsies required according to previous endoscopy and biopsy findings. The first 3 years of surveillance were reviewed to assess programme adherence, impact on endoscopy resources and the incidence of high\u2010grade dysplasia and adenocarcinoma in patients undergoing surveillance.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Four hundred five patients were enrolled in the surveillance programme, and 776 patient years of endoscopy follow\u2010up were analysed. Four\u2010quadrant biopsies every 2\u2003cm throughout the Barrett's oesophagus were performed in 89.8% of endoscopies. A total of 93.7% of patients had surveillance endoscopy performed at the appropriate time interval. Formalizing surveillance was followed by a decrease in the mean time interval for endoscopy surveillance from 16 months to 15 months, although the mode endoscopy surveillance interval lengthened from 1 year to 2 years. The mean number of biopsies per endoscopy increased from 5.9 to 7. In four patients, T1 stage oesophageal adenocarcinoma was identified, and in six patients, high\u2010grade dysplasia was identified (combined incidence of adenocarcinoma\/high\u2010grade dysplasia 1 per 77.6 endoscopy years of follow\u2010up).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Structured Barrett's surveillance detects malignant progression at an early stage, which provides opportunities for curative surgical or endoscopic intervention. Formalizing surveillance resulted in a high rate of adherence to agreed guidelines and rationalized the use of endoscopy resources without significantly increasing workload.<\/jats:p>","DOI":"10.1111\/j.1445-2197.2009.05107.x","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T05:44:33Z","timestamp":1257486273000},"page":"812-816","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Outcome of endoscopy surveillance for Barrett's oesophagus"],"prefix":"10.1111","volume":"79","author":[{"given":"Tim","family":"Bright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Schloithe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff A.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"1293","article-title":"Risk factors for Barrett's esophagus in community based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy","volume":"92","author":"Lieberman DA","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(89)80011-3"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4591"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31879"},{"key":"e_1_2_5_6_2","article-title":"Guidelines for the diagnosis and management of Barrett's columnar\u2010lined oesophagus","author":"British Society of Gastroenterology","year":"2005","journal-title":"August"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05910.x"},{"key":"e_1_2_5_8_2","first-page":"53","article-title":"Oesophageal cancer: screening and surveillance. Results of a consensus conference held at the 6th World Congress of the International Society of Diseases of the Oesophagus","volume":"9","author":"Stein HJ","year":"1996","journal-title":"Dis. Esophagus"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9007"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01586.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb05840.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7553.1320"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.001"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410003524"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.033837"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31879"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01275.x"},{"key":"e_1_2_5_18_2","first-page":"2","article-title":"Guidelines for the diagnosis and management of Barrett's columnar\u2010lined oesophagus","author":"British Society of Gastroenterology","year":"2005","journal-title":"August"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01230.x"},{"key":"e_1_2_5_20_2","first-page":"1","article-title":"Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk","volume":"21","author":"Kelty CJ","year":"2007","journal-title":"Scand. J. Gastroenterol."}],"container-title":["ANZ Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-2197.2009.05107.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-2197.2009.05107.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:17:52Z","timestamp":1698758272000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-2197.2009.05107.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1445-2197.2009.05107.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-2197.2009.05107.x","archive":["Portico"],"relation":{},"ISSN":["1445-1433","1445-2197"],"issn-type":[{"value":"1445-1433","type":"print"},{"value":"1445-2197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"2009-11-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}